Experiment: 2L6G

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	3D 1H-15N NOESY	1 mM [U-100% 13C; U-100% 15N] FOCAL ADHESION KINASE 1, LINKER, 22-MERIC PEPTIDE FROM PAXILLIN-1, 10 mM potassium phosphate-2, 0.1 % sodium azide-3, 5 mM LD4 PEPTIDE FROM PAXILLIN-4	90% H2O/10% D2O	10	6.5	AMBIENT Pa	310
2	3D 1H-13C NOESY	1 mM [U-100% 13C; U-100% 15N] FOCAL ADHESION KINASE 1, LINKER, 22-MERIC PEPTIDE FROM PAXILLIN-1, 10 mM potassium phosphate-2, 0.1 % sodium azide-3, 5 mM LD4 PEPTIDE FROM PAXILLIN-4	90% H2O/10% D2O	10	6.5	AMBIENT Pa	310
3	3D HCCH-TOCSY	1 mM [U-100% 13C; U-100% 15N] FOCAL ADHESION KINASE 1, LINKER, 22-MERIC PEPTIDE FROM PAXILLIN-1, 10 mM potassium phosphate-2, 0.1 % sodium azide-3, 5 mM LD4 PEPTIDE FROM PAXILLIN-4	90% H2O/10% D2O	10	6.5	AMBIENT Pa	310
4	3D HCCH-COSY	1 mM [U-100% 13C; U-100% 15N] FOCAL ADHESION KINASE 1, LINKER, 22-MERIC PEPTIDE FROM PAXILLIN-1, 10 mM potassium phosphate-2, 0.1 % sodium azide-3, 5 mM LD4 PEPTIDE FROM PAXILLIN-4	90% H2O/10% D2O	10	6.5	AMBIENT Pa	310
5	3D HNCA	1 mM [U-100% 13C; U-100% 15N] FOCAL ADHESION KINASE 1, LINKER, 22-MERIC PEPTIDE FROM PAXILLIN-1, 10 mM potassium phosphate-2, 0.1 % sodium azide-3, 5 mM LD4 PEPTIDE FROM PAXILLIN-4	90% H2O/10% D2O	10	6.5	AMBIENT Pa	310
6	3D CBCA(CO)NH	1 mM [U-100% 13C; U-100% 15N] FOCAL ADHESION KINASE 1, LINKER, 22-MERIC PEPTIDE FROM PAXILLIN-1, 10 mM potassium phosphate-2, 0.1 % sodium azide-3, 5 mM LD4 PEPTIDE FROM PAXILLIN-4	90% H2O/10% D2O	10	6.5	AMBIENT Pa	310
7	3D HNCO	1 mM [U-100% 13C; U-100% 15N] FOCAL ADHESION KINASE 1, LINKER, 22-MERIC PEPTIDE FROM PAXILLIN-1, 10 mM potassium phosphate-2, 0.1 % sodium azide-3, 5 mM LD4 PEPTIDE FROM PAXILLIN-4	90% H2O/10% D2O	10	6.5	AMBIENT Pa	310
8	3D HNCACB	1 mM [U-100% 13C; U-100% 15N] FOCAL ADHESION KINASE 1, LINKER, 22-MERIC PEPTIDE FROM PAXILLIN-1, 10 mM potassium phosphate-2, 0.1 % sodium azide-3, 5 mM LD4 PEPTIDE FROM PAXILLIN-4	90% H2O/10% D2O	10	6.5	AMBIENT Pa	310
9	2D 1H-15N HSQC	1 mM [U-100% 13C; U-100% 15N] FOCAL ADHESION KINASE 1, LINKER, 22-MERIC PEPTIDE FROM PAXILLIN-1, 10 mM potassium phosphate-2, 0.1 % sodium azide-3, 5 mM LD4 PEPTIDE FROM PAXILLIN-4	90% H2O/10% D2O	10	6.5	AMBIENT Pa	310
10	2D 1H-13C HSQC	1 mM [U-100% 13C; U-100% 15N] FOCAL ADHESION KINASE 1, LINKER, 22-MERIC PEPTIDE FROM PAXILLIN-1, 10 mM potassium phosphate-2, 0.1 % sodium azide-3, 5 mM LD4 PEPTIDE FROM PAXILLIN-4	90% H2O/10% D2O	10	6.5	AMBIENT Pa	310

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	800
2	Varian	INOVA	600

NMR Refinement
Method	Details	Software
SIMULATED ANNEALING, TORSION ANGLE DYNAMICS	THE SAMPLES USED ARE CONSTRUCTS IN WHICH ONE MOTIF IS TETHERED TO THE C-TERMINUS OF THE FAT DOMAIN VIA A GGSX LINKER AND THE OTHER LD MOTIF IS BOUND AS A FREE PEPTIDE. THE GGS LINKERS ARE UNSTRUCTURED AND COMPARISON OF SPECTRA LEAD US TO BELIEVE THEY DO NOT IMPOSE ANY CONSTRAINT UPON HOW THE TETHERED LD MOTIFS BIND TO FAT. HOWEVER WHEN ANALYZING THE STRUCTURE IN CYANA, THE PRESENCE OF THE GGS LINKER IN THE SEQUENCE INTERFERS WITH CYANA'S INITIAL ALIGNMENT OF THE 20 LOWEST ENERGY STRUCTURES AND THUS CONFUSES RMSD AND TARGET FUNCTION CALCULATIONS. WE FOUND THAT USING PSEUDO LINKERS IN CYANA RESOLVED THIS PROBLEM WITHOUT CHANGING THE STRUCTURES IN QUESTION AND SO WE CHOSE TO SUBMIT THE STRUCTURES IN THAT WAY. 2RP6 REPRESENTS A COMPOSITE STRUCTURE USING CONSTRAINTS OBTAINED FROM THE 2RP7 AND 2RP9 DATA SETS. IT DOES NOT REPRESENT A NEW CONSTRUCT IN ITSELF, BUT MOST ACCURATELY REPRESENTS THE COMPLETE COMPLEX STRUCTURE BETWEEN PAXILLIN AND FOCAL ADHESION KINASE.	CYANA

NMR Ensemble Information
Conformer Selection Criteria	target function
Conformers Calculated Total Number	500
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	refinement	CYANA		Guntert, Mumenthaler and Wuthrich
2	structure solution	CYANA		Guntert, Mumenthaler and Wuthrich
3	structure solution	Sparky		Goddard
4	structure solution	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
5	structure solution	MOLMOL		Koradi, Billeter and Wuthrich

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.